Tandem Diabetes Care Inc at Raymond James Institutional Investors Conference Transcript
All right. Good morning. I think we'll start. Welcome to the third day of the Raymond James Institutional Investors Conference. We certainly appreciate the packed house on the third day with the sun shining out there. So we appreciate that. Thank you. I'm Jayson Bedford. I cover the medical technology sector here at Raymond James. And it's really our pleasure to have with us Tandem Diabetes for the first time at this conference, I think.
So we have the company's CFO, Leigh Vosseller, and we have the company's CEO, John Sheridan, who will walk through the story.
Thanks, Jayson. It's nice to be here. Am I on? Okay, very nice see this morning. I think what I'd like to do is just kind of give you an overview of Tandem, where we're going, what the markets look like, our pipeline. And just give you a good sense of what you can expect from us over the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
